A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...
NEW YORK (Reuters Health) - A new study of an intensive and expensive form of prostate cancer therapy finds that doctors who stand to profit from the treatment are twice as likely to recommend it, ...
DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
Predictive value of a pathomics signature in de novo metastatic prostate cancer: An ancillary study of the PEACE-1 phase 3 trial. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for ...
Advances in radiotherapy are rapidly transforming how prostate cancer is treated, offering patients more precise, less invasive options that can fit more easily around everyday life ...
Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results